RISPERIDEX 4 MG

देश: इसराइल

भाषा: अंग्रेज़ी

स्रोत: Ministry of Health

सक्रिय संघटक:

RISPERIDONE

थमां उपलब्ध:

DEXCEL PHARMA TECHNOLOGIES LTD

ए.टी.सी कोड:

N05AX08

फार्मास्यूटिकल फॉर्म:

CAPLETS

रचना:

RISPERIDONE 4 MG

प्रशासन का मार्ग:

PER OS

प्रिस्क्रिप्शन प्रकार:

Required

द्वारा बनाया गया:

DEXCEL LTD, ISRAEL

चिकित्सीय समूह:

RISPERIDONE

चिकित्सीय क्षेत्र:

RISPERIDONE

चिकित्सीय संकेत:

Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors

प्राधिकरण की तारीख:

2021-05-31